Skip to main content

Table 2 Endpoint events in the study cohort at 30 days

From: Comparison of the prognosis for different onset stage of cardiogenic shock secondary to ST-segment elevation myocardial infarction

EventsNon-CS (n = 562)CS on admission (n = 32)Developed CS (n = 81)p-value
All cause death, n (%)13(2)1(3)2(2)0.956
MACE
 Cardiac death, n (%)13(2)1(3)2(2)0.956
 Angina/Recurrent MI, n (%)4(1)0(0)0(0)0.667
 Worsening of cardiac function, n (%)2(0)1(3)1(1)0.101
 Non-fatal stroke, n (%)0(0)1(3)0(0)P < 0.001
  1. MI Myocardial infarction, MACE Major adverse cardiac events